At high doses, glucocorticoids such as dexamethasone and prednisone affect MM cells potentially via an anti-NF-κB transcriptional program mediated by the glucocorticoid receptor (NR3C1)49. The gene discussed is NFKB1; the disease is Miyoshi myopathy.